As the post-pandemic world of work continues to evolve, so do recruiters’ strategies and tools for finding and engaging top talent. In 2023, we are seeing these seven trends:1. Employer branding is becoming an increasingly important factor in the recruitment…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Teva Pharma Japan to Postpone NHI Price Listing of All Generics Including Valsartan in June
May 23, 2014
-
ORGANIZATION Dainippon Pres. Tada Elected New Chief of JPMA
May 22, 2014
-
BUSINESS AZ to Highlight Global Data to Push Forxiga: Primary Care Head
May 21, 2014
-
REGULATORY MHLW, MOF, Cabinet Office to Come to Agreement on Once-yearly NHI Price Revision by End May
May 21, 2014
-
BUSINESS Improper Staffer Involvement in 4 More Japan CML Programs: Novartis
May 20, 2014
-
REGULATORY PIC/S Committee OKs Japan’s Accession from July 2014
May 20, 2014
-
ACADEMIA Sapporo Hospital Sorry for Ethical Guidelines Violations in Nesp Clinical Study
May 19, 2014
-
BUSINESS Jury Finds in Favor of Takeda in Actos Lawsuit, Turning Down Plaintiff’s Claim
May 19, 2014
-
BUSINESS Generic Makers See Softer Sales Growth in FY2013
May 16, 2014
-
BUSINESS Daiichi Sankyo Chair Shoda to Bow Out, Become Adviser
May 16, 2014
-
REGULATORY Chuikyo OKs NHI Price Listing of SGLT-2 Inhibitors, New Point-Based Calculations Adopted from This Time
May 15, 2014
-
BUSINESS Santen Acquires Merck’s Eye Drugs in Japan, Key Markets
May 14, 2014
-
REGULATORY PIC/S to Discuss Japan’s Accession at Upcoming Meeting in Rome; MHLW Anticipates Formal Approval
May 14, 2014
-
BUSINESS 4 Major Wholesalers’ Average Operating Margin Tops 1% Mark, Signaling Biz Recovery
May 13, 2014
-
BUSINESS Astellas Pres. “Aware” of Rumored Marriage with Daiichi Sankyo, but Denies Any Merger at This Time
May 13, 2014
-
BUSINESS FY2013 Japan Ethical Drug Market Crosses 10 Trillion Yen Mark for 1st Time: IMS
May 12, 2014
-
BUSINESS MTPC to Push Tenelia, Canaglu to Compete in Diabetes Field
May 9, 2014
-
BUSINESS Eisai Moves to Boost Global Use of Products via Emerging Market Businesses
May 8, 2014
-
REGULATORY Pilot Program for Compassionate Access System Gets Underway with Sanofi’s Cabazitaxel
May 7, 2014
-
REGULATORY Joint Panel of Health, Science Ministries Wraps Up Talks on Ethics Code for Epidemiological, Clinical Research
May 2, 2014
ページ
Novo Nordisk’s weight-loss medication Wegovy (semaglutide) was approved in Japan in March. While it skipped the May round of reimbursement listing, physicians eagerly await the arrival of what would be the first new obesity drug in three decades. Other companies…
Japan’s health ministry on April 27 presented an outline of a report to be compiled next month by its key…
A key Japanese reimbursement policy panel on December 16 approved the government-backed plan for the FY2023 “off-year” drug price revision.…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…